Protocol Summary
Provide clear aims, study design, inclusion/exclusion criteria, sample size rationale, and primary endpoints so reviewers understand the scientific basis.
A complete, accurate Healthcare IRB Review Form speeds ethical review, reduces requests for clarification, and documents measures that protect participants and data. It creates a clear administrative record for sponsors, auditors, and regulatory bodies while supporting timely study start-up.
The Healthcare IRB Review Form involves multiple roles across an institution; accurate role assignment prevents delays.
Clear responsibilities help the IRB and research team exchange information efficiently and maintain oversight throughout the study lifecycle.
The PI certifies that the research will be conducted according to the submitted protocol, ensures informed consent is obtained, and accepts responsibility for regulatory reporting and participant safety. The PI must provide credentials and contact information for IRB follow-up and oversight.
The IRB Chair or designated reviewer signs off on approval, documents conditions of approval, and ensures the board's decision aligns with 45 CFR part 46 and institutional policy. Their signature formalizes the IRB determination and applicable continuing review schedule.
Provide clear aims, study design, inclusion/exclusion criteria, sample size rationale, and primary endpoints so reviewers understand the scientific basis.
Attach the exact consent and assent forms with version dates, readability level, and translations where applicable for accurate review.
Describe de-identification, storage location, access controls, and any plans for data sharing or repositories.
Include DSMB plans, adverse event reporting procedures, and stopping rules if applicable to participant safety oversight.
Attach recruitment scripts, advertisements, and screening tools so the IRB can evaluate voluntariness and undue influence.
Disclose financial relationships or other COIs for investigators and mitigation strategies to preserve objectivity.
| Field | Configuration |
|---|---|
| Required Signatures | Enforce PI and department sign-off |
| Attachments | Require consent, protocol, and surveys |
| Routing Rules | Auto-route by study risk or department |
| Notifications | Email alerts for missing items |
The chosen platform should offer compliance controls (BAA for HIPAA, 21 CFR Part 11 features when needed) and integrate with institutional systems for storage and reporting.
4–8 weeks for convened IRBs
2–4 weeks for qualifying minimal-risk studies
Often annual; see 45 CFR §46.109
2–6 weeks depending on scope
Report promptly per IRB policy and sponsor terms
All required fields and attachments uploaded
Administrative check for completeness
Full board or expedited committee decision
Ongoing reporting and compliance checks